In this webinar, we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH) about the challenges and opportunities for reimbursement in the German-speaking markets.
Listen to the podcast:
This episode is also available as a podcast. Listen below or search ‘Pharma Market Access Insights – from Mtech Access’ on Spotify, Apple Podcasts or Google Podcasts.
When developing global market access and reimbursement strategies, it is important to consider the key differences in pathways and decision-making between markets. What works in the US often needs significant adaptation to work in Europe, where there are clear differences in requirements between countries that may impact evidence generation and pricing strategies, or require adaptation of value propositions to ensure they resonate with stakeholders.
In this webinar, we explore the market access and pricing challenges in Germany, Austria and Switzerland. Clare and Stefan discuss:
- Preparing for access to Switzerland – a European market outside the EU
- Pricing strategy and HTA decision-making in Austria under the new Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA)
- Launching in Germany – is this still one of the most attractive European markets?
- The Financial Stabilisation Act in Germany – what this means for drug pricing
More about our speaker
Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH)
Stefan has specialised in pricing, health economics, payer strategies, dossier development and submission, and negotiations since 2004. He is the founder and CEO of MArS Market Access & Pricing Strategy GmbH in Germany, and P&N – Pricing & Negotiations in Health Care, Ltd. in Canada. Stefan also co-founded mAxInsights, which uses artificial intelligence (AI) to support customers in their Market Access activities.
Stefan invented the virtual reality negotiation platform also utilised within The Negotiation Lab. He hosts the bi-weekly Market Access Podcast MAP, is co-editor of the book ‘Digital Health in Germany – Market Access for Innovation’ and the lead author of the book chapter ‘Reimbursement Value and Pricing in Business Planning in Health Care’. He also teaches Market Access at several universities in Germany.
Stefan started his career as a payer consultant for the successful global product launches by various global pharmaceutical and medical device/diagnostic companies. He has co-authored more than 50 peer-reviewed scientific articles and more than 400 scientific abstracts. Stefan holds a PhD in Health Economics, a Master of Science in Economics, and a Diploma in Clinical Trials.
We were delighted to welcome Stefan to the Global Whispers webinar series.
The Global Whispers webinar series
This webinar is the third in our Global Whispers series. For over 2 years, Mtech Access have presented an industry-renowned NHS Whispers webinar series, where we interview experts from the UK healthcare system about the market landscape and the evolving challenges in the NHS. Following the success of this series, we are launching a new series looking at global market access challenges facing the Pharmaceutical and Medtech industries and offering insights into key launch markets.
In May, Michael Sassano (CEO – SOMAÍ Pharmaceuticals) joined us to share his global market access journey in cannabinoid pharmaceuticals. In June, we spoke to Shefali Shah (Global VP, Market Value and Commercial Effectiveness – MindMaze) about the challenges and opportunities facing digital therapies looking to gain market access. Later this year we plan to welcome speakers who can share their perspectives on global market access and/or specific markets.